Comment on 'Proton Pump Inhibitors. Risks and Rewards and Emerging Consequences to the Gut Microbiome'.
作者信息
Toda Katsuhiro
机构信息
Department of Orthopedic Surgery, Kitahiroshima Town Toyohira Hospital, Kita-Hiroshima Town, Yamagata-Gun, Hiroshima, Japan.
出版信息
Nutr Clin Pract. 2019 Feb;34(1):172. doi: 10.1002/ncp.10218. Epub 2018 Nov 21.
PMID:30462863
Abstract
摘要
相似文献
1
Comment on 'Proton Pump Inhibitors. Risks and Rewards and Emerging Consequences to the Gut Microbiome'.
Nutr Clin Pract. 2019 Feb;34(1):172. doi: 10.1002/ncp.10218. Epub 2018 Nov 21.
2
Response to Comment on 'Proton Pump Inhibitors. Risks and Rewards and Emerging Consequences to the Gut Microbiome'.
Nutr Clin Pract. 2019 Feb;34(1):173. doi: 10.1002/ncp.10217. Epub 2018 Nov 21.
3
Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.质子泵抑制剂：对肠道微生物组的风险与收益和新兴后果。
Nutr Clin Pract. 2018 Oct;33(5):614-624. doi: 10.1002/ncp.10181. Epub 2018 Aug 2.
4
Proton pump inhibitor use associated with changes in gut microbiota composition.质子泵抑制剂的使用与肠道微生物群组成的变化有关。
Gut. 2018 Jul;67(7):1369-1370. doi: 10.1136/gutjnl-2017-315306. Epub 2017 Oct 9.
5
Editorial: further evidence that proton pump inhibitors may impact on the gut microbiota.社论：质子泵抑制剂可能影响肠道微生物群的进一步证据。
Aliment Pharmacol Ther. 2016 May;43(10):1104-5. doi: 10.1111/apt.13596.
6
Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?长期质子泵抑制剂治疗会影响肠道微生物群的健康吗？
Gut Liver. 2016 Nov 15;10(6):865-866. doi: 10.5009/gnl16438.
7
Oral microbiome alterations of healthy volunteers with proton pump inhibitor.质子泵抑制剂对健康志愿者口腔微生物组的影响。
J Gastroenterol Hepatol. 2018 May;33(5):1059-1066. doi: 10.1111/jgh.14040. Epub 2018 Feb 14.
8
Heartburn Meds Alter the Gut.治疗胃酸反流的药物会改变肠道。
Sci Am. 2016 May;314(5):17. doi: 10.1038/scientificamerican0516-17.
9
Proton pump inhibitor use status does not modify the microbiome signature for cirrhosis.质子泵抑制剂的使用状况不会改变肝硬化的微生物组特征。
Cell Metab. 2021 Mar 2;33(3):457. doi: 10.1016/j.cmet.2021.02.013.
10
Treatment regimens may compromise gut-microbiome-derived signatures for liver cirrhosis.治疗方案可能会影响肝硬化的肠道微生物组衍生特征。
Cell Metab. 2021 Mar 2;33(3):455-456. doi: 10.1016/j.cmet.2021.02.012.
Zotero 插件